Vivek Ramaswamy Is a Fraud—and Always Has Been | Opinion
Sep 1, 2023 · According to his version, he helmed the leadership of Roivant, a multi-billion-dollar American pharmaceutical company he founded, and gallantly relinquished his CEO role in 2021 due to his...
Vivek Ramaswamy-founded company to sell drug in $7B deal - New York Post
Jul 14, 2023 · A pharmaceutical company founded by Republican presidential candidate Vivek Ramaswamy is reportedly in talks to sell an experimental drug in a deal that could be valued at more than $7...
How Vivek Ramaswamy helped make Martin Shkreli the ‘pharma …
May 23, 2023 · Vivek Ramaswamy, the Republican presidential candidate who made a fortune in biotech, once was involved in a significant investment in a biotech company run by disgraced investor Martin Shkreli.
Vivek Ramaswamy's Biotech Firm Flipped $15 Million Asset Into …
Oct 24, 2023 · A biotech firm founded by Vivek Ramaswamy turned $15 million into $5 billion by flipping a bowel-disease treatment that Pfizer gave it for free
The 30-Year-Old CEO Conjuring Drug Companies From Thin Air - Forbes
Sep 9, 2015 · When Ramaswamy struck out on his own last May, QVT and Dexcel Pharma, an Israeli firm that had noticed his track record, backed him to the tune of nearly $100 million.
Roivant Sciences - Wikipedia
Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and …
Vivek Ramaswamy: Big Pharma Is a Big Problem - Shortform
Feb 7, 2024 · According to Vivek Ramaswamy, Big Pharma is a big problem. On a podcast episode of The Shawn Ryan Show, Ramaswamy cited concerns about inefficiencies, inconsistencies, and ethics in the pharmaceutical industry. Continue reading for a summary of Ramaswamy’s take on Big Pharma as discussed in the episode. Vivek Ramaswamy on …
Who is Vivek Ramaswamy — the biotech entrepreneur
Feb 27, 2023 · Vivek Ramaswamy was hailed as a wunderkind when he blazed onto the pharma scene in the late 2000s, first as an investment analyst, and later as the co-founder and CEO of Roivant Sciences. Now he’s taking on a new challenge — a U.S. presidential run.
How Vivek Ramaswamy Plans To Speed Drug Research And Cure ... - Forbes
Mar 7, 2017 · Ramaswamy, now 31, targets promising drugs from big pharma which—because of corporate strategy, market tastes, or politics—have stalled in clinical trials. His parent company Roivant buys...
Vivek Ramaswamy's Net Worth: How Harvard-Yale graduate …
Nov 13, 2024 · Vivek Ramaswamy, a self-made billionaire, made his fortune in biotech. He founded Roivant Sciences, a company that develops pharmaceuticals. Ramaswamy also invests in technology and cryptocurrency.
- Some results have been removed